+143.3%
MRNA vs UTHR
+1.8%
+141.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | UTHR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +1.8% | -5.1% | -5.6% |
| 7D | -10.1% | +3.0% | -13.1% | -13.6% |
| 30D | +126.7% | -4.3% | +131.0% | +139.9% |
| 3M | +184.1% | -8.4% | +192.5% | +205.4% |
| 6M | +143.3% | -4.2% | +147.5% | +159.8% |
| All | +143.3% | +1.8% | +141.5% | +159.8% |
Cumulative growth
Daily Returns
Daily percentage return beside UTHR.
Daily Out/Under-Performance
Portfolio return minus UTHR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × UTHR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded UTHR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling